U.S. market Closed. Opens in 1 day 12 hours 19 minutes

HEPA | Hepion Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-06-302016-06-302015-06-302014-06-302013-06-30
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue67.13K77.46K86.07K34.52K26.74KN/AN/AN/AN/AN/AN/A
Gross Profit-67.13K-77.46K-86.07K-34.52K-26.74KN/AN/AN/AN/AN/AN/A
Operating Expenses48.45M43.62M30.40M20.15M7.77M14.59M21.02M20.81M13.96M1.67MN/A
Selling, General & Admin9.62M10.35M10.01M8.15M4.59M7.00M7.37M5.79M5.56M1.36MN/A
Research & Development35.64M33.27M20.40M12.00M3.18M7.59M13.65M15.02M8.40M314.25KN/A
Other Operating Expenses3.19MN/AN/AN/A-179.65K-108.94KN/AN/AN/AN/AN/A
Operating Income-48.45M-45.49M-30.40M-20.15M-7.77M-14.59M-21.02M-20.81M-13.96M-1.67MN/A
Other Expenses / Income-887.11K-1.46M-2.31M-146.05K379.06K4.95M4.22M3.81M-387.90K-3.61MN/A
Before Tax Income-49.34M-45.08M-32.72M-20.32M-7.95M-9.99M-16.80M-17.00M-14.35M-5.28MN/A
Income Tax Expenses409.02K-2.88M8.86K30.58K-908.68K-536.00K-1.91MN/AN/AN/AN/A
Net Income-48.93M-42.20M-32.72M-20.35M-7.04M-9.45M-14.89M-17.00M-14.35M-5.28MN/A
Interest Expenses-9.46K10.16K8.86K31.23K555.00K339.16K-4.22MN/AN/AN/AN/A
Basic Shares Outstanding3.97M3.81M3.51M483.89K102.16K9.19K104.09K48.32K38.85K22.89K33.00K
Diluted Shares Outstanding3.97M3.81M3.51M483.89K102.16K9.19K104.18K48.32K38.85K22.89K33.00K
EBITDA-45.19M-43.54M-30.32M-20.11M-7.92M-14.68M-16.77M-20.78M-13.94M-1.67MN/A
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-48.53M-45.07M-32.70M-20.29M-7.39M-9.65M-21.02M-17.00M-14.35M-5.28MN/A
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-06-302016-06-302015-06-302014-06-302013-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙